RS

Rajendra Sheshrao Dhole

Active Director Director DIN 02861133
DIN 02861133 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value •••• Premium profile

About Rajendra Sheshrao Dhole

Data last updated:

Rajendra Sheshrao Dhole is a Director at Rholence Pharmaceuticals Private Limited (since 2010). The company operates in Pharma. Rholence Pharmaceuticals Private Limited reported revenue of ₹73.6 Lakh (FY 2024).

DIN 02861133
Primary Designation Director
Industry Pharma
First Appointment 12 Feb 2010
Oldest Company Age 16 yrs
Largest company Rholence Pharmaceuticals Private Limited · ₹73.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Feb 20102010₹73.6 Lakh (FY 2024)Active

Board colleagues of Rajendra Sheshrao Dhole

Directorship timeline

Open interactive timeline →
Rholence Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajendra Sheshrao Dhole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Sheshrao Dhole

Rajendra Sheshrao Dhole currently holds 1 directorship: Rholence Pharmaceuticals Private Limited (Director, since 12 Feb 2010, revenue ₹73.6 Lakh (FY 2024)).

Rajendra Sheshrao Dhole was first appointed on 12 Feb 2010 as Director at Rholence Pharmaceuticals Private Limited.

The current boards of Rajendra Sheshrao Dhole's companies include Pratima Rajendra Dhole (Rholence Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available